Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Corticotherapy and suicidal behavior: A case report].
[Capabilities of positron emission tomography to study mecha-nisms of multiple sclerosis: own data and literature].
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention.
White Matter Injury in Ischemic Stroke.
3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.
Metabolomics of Neurodegenerative Diseases.
Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells.
Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor.
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out.
Acquired demyelinating disorders of central nervous system: A pediatric cohort.
Robotic gait rehabilitation and substitution devices in neurological disorders: where are we now?
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model.
Palliative treatment of chronic neurologic disorders.
A multicentre prospective study of Guillain-Barre Syndrome in Japan: a focus on the incidence of subtypes.
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
Including a subject-paced trial may make the PASAT more acceptable for MS patients.
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica.
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
Molecular analysis of polimorphisms in HLA-CLASS II DRB1* and IL7Rα possibly associated with multiple sclerosis susceptibility in a population sample of Rio de Janeiro.
The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results.
Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases.
Pages
« first
‹ previous
…
571
572
573
574
575
576
577
578
579
…
next ›
last »